Gilead Sciences shows strong Q1 execution, pipeline momentum, and margin upside, led by HIV and PrEP launches. See why GILD ...

During Q1 of 2025, the portfolio outperformed the MSCI EAFE benchmark driven primarily by security-specific effects, and sector allocation was also additive. Read more here.

While reaching retirement age can be both a blessing and a curse, relying on the U.S. government to provide for your needs is ...